1 – 21 of 21
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Predictive Models for Assessing Patients’ Response to Treatment in Metastatic Prostate Cancer : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management : A PIONEER Analysis Based on Big Data
(
- Contribution to journal › Article
- 2023
-
Mark
The need for core outcome sets in renal cancer clinical effectiveness research
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer
(
- Contribution to journal › Article
-
Mark
Diagnostic and prognostic factors in patients with prostate cancer : a systematic review
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Diagnostic and prognostic factors in patients with prostate cancer : A systematic review protocol
(
- Contribution to journal › Scientific review
- 2020
-
Mark
A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and the Effect on Survival in Bladder Cancer Patients
(
- Contribution to journal › Scientific review
-
Mark
Introducing PIONEER : a project to harness big data in prostate cancer research
(
- Contribution to journal › Article
- 2019
-
Mark
Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer : A Swedish nationwide population-based cohort study
(
- Contribution to journal › Article
-
Mark
Reasons for Discontinuing Active Surveillance : Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium
(
- Contribution to journal › Article
- 2018
-
Mark
The Movember Foundation's GAP3 cohort : a profile of the largest global prostate cancer active surveillance database to date
(
- Contribution to journal › Article
-
Mark
Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria
(
- Contribution to journal › Article
- 2017
-
Mark
Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events
(
- Contribution to journal › Article
-
Mark
Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease : Semi-ecologic, Nationwide, Population-based Study
(
- Contribution to journal › Article
- 2016
-
Mark
Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base-a refined prostate cancer trajectory.
(
- Contribution to journal › Article
-
Mark
Interpretation of conventional survival analysis and competing risk analysis : An example of hypertension and prostate cancer
(
- Contribution to journal › Article
- 2012
-
Mark
Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer Project.
(
- Contribution to journal › Article
- 2010
-
Mark
Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
(
- Contribution to journal › Article
-
Mark
Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden.
(
- Contribution to journal › Article